279 research outputs found
Method of calculating variable section shafts shear deformations
This article considered method to measure low-frequency angular oscillations of rotors of electric machines and solved the problem of assess shear deformations of rotating shafts in transient conditions. Method of calculating torsional torques is considered by the example of electric generator shaft of diesel generator unit. This method allows taking into account the angular deformations of the rotating shafts, and reducing vibration overloads, and increasing in both resource and reliability
ΠΠ΅ΡΠΎΠ΄ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΊΠΎΠ½ΡΠΈΠ³ΡΡΠ°ΡΠΈΠΉ ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅ΠΆΠΈΠΌΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΠΊΡΠ°
Π‘Π»ΠΎΠΆΠ½ΠΎΡΡΡ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠ² Ρ ΠΏΠ΅ΡΠ΅ΡΡΡΠ°ΠΈΠ²Π°Π΅ΠΌΠΎΠΉ ΡΡΡΡΠΊΡΡΡΠΎΠΉ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ ΡΡΠ΅ΡΠ° ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΈΡ
Ρ ΠΎΠΊΡΡΠΆΠ°ΡΡΠ΅ΠΉ ΡΡΠ΅Π΄ΠΎΠΉ ΠΈ ΡΠ²ΡΠ·Π°Π½Π° Ρ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΈΡΠ»Π° Π²Ρ
ΠΎΠ΄ΡΡΠΈΡ
Π² ΠΈΡ
ΡΠΎΡΡΠ°Π² ΡΠ»Π΅ΠΌΠ΅Π½ΡΠΎΠ² ΠΈ ΠΏΠΎΠ΄ΡΠΈΡΡΠ΅ΠΌ, Π° ΡΠ°ΠΊΠΆΠ΅, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ, ΡΡΡΠ΅ΠΌΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΡΠΎΡΡΠΎΠΌ ΡΠΈΡΠ»Π° Π²Π½ΡΡΡΠ΅Π½Π½ΠΈΡ
ΡΠ²ΡΠ·Π΅ΠΉ, ΠΈ ΠΏΡΠΎΡΠ²Π»ΡΠ΅ΡΡΡ Π² ΡΠ°ΠΊΠΈΡ
Π°ΡΠΏΠ΅ΠΊΡΠ°Ρ
, ΠΊΠ°ΠΊ ΡΡΡΡΠΊΡΡΡΠ½Π°Ρ ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡ, ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡ Π²ΡΠ±ΠΎΡΠ° ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ, ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡ ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ. ΠΠ°Π½Π½ΡΠ΅ ΡΠΈΡΡΠ΅ΠΌΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΡΡΡ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ Π½Π΅ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ½Π½ΠΎΡΡΠΈ, ΡΠ²ΡΠ·Π°Π½Π½ΠΎΠΉ Ρ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΠ΅Π»Π΅ΠΉ ΠΈ Π·Π°Π΄Π°Ρ, ΡΡΠΎΡΡΠΈΡ
ΠΏΠ΅ΡΠ΅Π΄ ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠΌ, Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ΠΌ Π²ΠΎΠ·ΠΌΡΡΠ°ΡΡΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ Π²Π½Π΅ΡΠ½Π΅ΠΉ ΡΡΠ΅Π΄Ρ ΠΈ ΠΈΠΌΠ΅ΡΡΠΈΡ
ΡΠ΅Π»Π΅Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΠΉ ΠΈ/ΠΈΠ»ΠΈ Π½Π΅ΡΠ΅Π»Π΅Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ. Π£ΠΊΠ°Π·Π°Π½Π½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠ²ΡΠ·Π°Π½Ρ Π½Π΅ ΡΠΎΠ»ΡΠΊΠΎ Ρ Π½Π΅ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΡΠΌΠΈ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΡΠΌΠΈ Π²Π½Π΅ΡΠ½Π΅ΠΉ ΡΡΠ΅Π΄Ρ, Π½ΠΎ ΠΈ Ρ ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²ΠΎΠΌ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠ΅ΠΆΠΈΠΌΠΎΠ² (Π²ΠΈΠ΄ΠΎΠ²) ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΡΡΠΈΡ
ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ ΡΠ΅ΡΠ°Π΅ΠΌΡΡ
Π·Π°Π΄Π°Ρ ΠΈ ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΈΡ
ΡΠ΅ΡΠ΅Π½ΠΈΡ. ΠΠ°ΠΊ ΠΏΡΠ°Π²ΠΈΠ»ΠΎ, ΡΠΈΡΡΠ΅ΠΌΡ Ρ ΡΠΈΠΊΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΠΎΠΉ, Π½Π°ΡΡΡΠ°ΠΈΠ²Π°Π΅ΠΌΡΠ΅ ΠΎΠ±ΡΡΠ½ΠΎ Π½Π° ΡΡΡΠ°Π½ΠΎΠ²ΠΈΠ²ΡΠΈΠΉΡΡ (ΠΊΠ°ΠΊΠΎΠΉ-ΡΠΎ Π·Π°Π΄Π°Π½Π½ΡΠΉ) ΡΠ΅ΠΆΠΈΠΌ, Π½Π΅ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°ΡΡ Π½Π°ΠΈΠ»ΡΡΡΠ΅Π³ΠΎ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π² Π΄ΡΡΠ³ΠΈΡ
ΡΠ΅ΠΆΠΈΠΌΠ°Ρ
. ΠΠΎΡΡΠΎΠΌΡ ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅ΠΆΠΈΠΌΠ½ΠΎΡΡΡ ΠΈ Π½Π΅ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΠΎΡΡΡ ΡΡΠ»ΠΎΠ²ΠΈΠΉ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΎΠ±ΡΡΠ»Π°Π²Π»ΠΈΠ²Π°ΡΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ Π°Π½Π°Π»ΠΈΠ·Π° ΠΈ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΊΠΎΠ½ΡΠΈΠ³ΡΡΠ°ΡΠΈΠΈ ΠΈ ΡΠ΅ΠΊΠΎΠ½ΡΠΈΠ³ΡΡΠ°ΡΠΈΠΈ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΠΌΡΡ
ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠ², ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΡΡ
Π½Π° ΠΈΠ½ΡΠ΅Π»Π»Π΅ΠΊΡΡΠ°Π»ΡΠ½ΡΡ
ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Π°Ρ
. ΠΡΠΈ ΡΡΠΎΠΌ Π½Π° ΡΡΠ°ΠΏΠ°Ρ
ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΠΈ ΠΏΡΠΎΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠ² Ρ ΠΏΠ΅ΡΠ΅ΡΡΡΠ°ΠΈΠ²Π°Π΅ΠΌΠΎΠΉ ΡΡΡΡΠΊΡΡΡΠΎΠΉ Π΄ΠΎΠ»ΠΆΠ½Ρ Π±ΡΡΡ ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½Ρ ΡΠ°ΠΊΠΈΠ΅ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Π°Π½Π½ΡΠ΅ ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π° ΡΠ΅ΠΆΠΈΠΌΠΎΠ² ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΡΡΡΡΠΊΡΡΡ, Π° ΡΠ°ΠΊΠΆΠ΅, Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ, Π²Π½Π΅ΡΡΠ½ ΡΠ°ΠΊΠΎΠΉ ΡΡΠΎΠ²Π΅Π½Ρ ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΡΡΠΈ Π² ΡΠΊΠ°Π·Π°Π½Π½ΡΠ΅ ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π° Ρ ΡΡΠ΅ΡΠΎΠΌ ΠΏΡΠΎΡΡΡΠ°Π½ΡΡΠ²Π΅Π½Π½ΠΎ-Π²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
, ΡΠ΅Ρ
Π½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠ³ΡΠ°Π½ΠΈΡΠ΅Π½ΠΈΠΉ, ΠΏΡΠΈ ΠΊΠΎΡΠΎΡΡΡ
Π½Π° ΡΡΠ°ΠΏΠ΅ ΠΈΡ
ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΠΎ ΡΠ΅Π»Π΅Π²ΠΎΠΌΡ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΡ ΠΈΠΌΠ΅Π»Π°ΡΡ Π±Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ Π³ΠΈΠ±ΠΊΠΎ ΡΠ΅Π°Π³ΠΈΡΠΎΠ²Π°ΡΡ Π½Π° Π²ΡΠ΅ ΡΠ°ΡΡΡΡΠ½ΡΠ΅ ΠΈ Π½Π΅ΡΠ°ΡΡΡΡΠ½ΡΠ΅ Π½Π΅ΡΡΠ°ΡΠ½ΡΠ΅ ΡΠΈΡΡΠ°ΡΠΈΠΈ, Π²ΡΠ·ΡΠ²Π°ΡΡΠΈΠ΅ ΡΡΡΡΠΊΡΡΡΠ½ΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΎΠ±ΡΠ΅ΠΊΡΠ°. Π‘ ΡΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΎΡΠΊΠΈ Π·ΡΠ΅Π½ΠΈΡ, ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΡΠΊΠ°Π·Π°Π½Π½ΡΡ
Π·Π°Π΄Π°Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ Π² ΡΠ°ΠΌΠΊΠ°Ρ
ΡΠ°ΠΊΠΎΠ³ΠΎ Π²Π°ΠΆΠ½Π΅ΠΉΡΠ΅Π³ΠΎ ΠΊΠ»Π°ΡΡΠ° ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
Π½Π°ΡΡΠ½ΠΎ-ΡΠ΅Ρ
Π½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π΄Π°Ρ, ΠΊΠ°ΠΊ Π·Π°Π΄Π°ΡΠΈ ΠΌΠ½ΠΎΠ³ΠΎΠΊΡΠΈΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΊΠΎΠ½ΡΠΈΠ³ΡΡΠ°ΡΠΈΠΉ ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅ΠΆΠΈΠΌΠ½ΡΡ
ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠ² Π½Π° ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΡΠ°ΠΏΠ°Ρ
ΠΈΡ
ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΈΠΊΠ»Π°. Π Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΡΠ°ΡΡΠ΅ ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½ ΠΌΠ΅ΡΠΎΠ΄ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΠΊΠ°Π·Π°Π½Π½ΡΡ
Π·Π°Π΄Π°Ρ, ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΡΠΉ Π½Π° ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½ΠΎΠΉ Π°Π²ΡΠΎΡΠ°ΠΌΠΈ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΠΈΠΈ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π³Π΅Π½ΠΎΠΌΠ° ΡΠ»ΠΎΠΆΠ½ΡΡ
ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅ΠΆΠΈΠΌΠ½ΡΡ
ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠ². ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π΄Π°Π½Π½ΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΠΈΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ Π² ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ Π²ΠΈΠ΄Π΅ Ρ
ΡΠ°Π½ΠΈΡΡ ΡΠ²Π½ΡΠ΅ ΠΈ Π½Π΅ΡΠ²Π½ΡΠ΅ Π·Π½Π°Π½ΠΈΡ ΡΠΊΡΠΏΠ΅ΡΡΠΎΠ² ΠΎ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠΈ ΡΠ»Π΅ΠΌΠ΅Π½ΡΠΎΠ² ΠΈ ΠΏΠΎΠ΄ΡΠΈΡΡΠ΅ΠΌ ΠΎΠ±ΡΠ΅ΠΊΡΠ° ΠΏΡΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΡΠ΅ΠΆΠΈΠΌΠΎΠ² ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΡΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ΅ Π²ΡΡΠΈΡΠ»Π΅Π½ΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ ΠΎΠΏΡΠΈΠΌΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ ΠΏΠ΅ΡΡΠΈΠΌΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠ΅Π½ΠΎΠΊ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π½Π°Π΄Π΅ΠΆΠ½ΠΎΡΡΠΈ ΠΎΠ΄Π½ΠΎΡΠΎΠ΄Π½ΡΡ
/Π½Π΅ΠΎΠ΄Π½ΠΎΡΠΎΠ΄Π½ΡΡ
, ΠΌΠΎΠ½ΠΎΡΠΎΠ½Π½ΡΡ
/Π½Π΅ΠΌΠΎΠ½ΠΎΡΠΎΠ½Π½ΡΡ
, ΡΠ°Π²Π½ΠΎΡΠ΅Π½Π½ΡΡ
/Π½Π΅ΡΠ°Π²Π½ΠΎΡΠ΅Π½Π½ΡΡ
ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅ΠΆΠΈΠΌΠ½ΡΡ
ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠ². ΠΠ»Ρ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π·Π°Π΄Π°ΡΠΈ ΠΌΠ½ΠΎΠ³ΠΎΠΊΡΠΈΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π²ΡΠ±ΠΎΡΠ° ΡΡΠ΅Π±ΡΠ΅ΠΌΠΎΠ³ΠΎ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° Π½Π΅Π΄ΠΎΠΌΠΈΠ½ΠΈΡΡΠ΅ΠΌΡΡ
Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² ΠΊΠΎΠ½ΡΠΈΠ³ΡΡΠ°ΡΠΈΠΉ ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅ΠΆΠΈΠΌΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΠΊΡΠ°, ΡΠ°Π²Π½ΠΎΠΌΠ΅ΡΠ½ΠΎ ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΡΡ
Π² ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
(ΠΏΠ°ΡΠ΅ΡΠΎΠ²ΡΠΊΠΈΡ
) Π°Π»ΡΡΠ΅ΡΠ½Π°ΡΠΈΠ², Π±ΡΠ»Π° ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π° ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠΈΡ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΈΠ½ΡΠ΅ΡΠ²Π°Π»ΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΠΊΡΠΈΠΊΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΏΠΎΡΡΠ΄ΠΎΡΠ΅Π½ΠΈΡ (ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΡΡΡΡΠΏΠΎΠΊ) ΠΈ ΠΎΠΏΠ΅ΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ°ΡΡΠ΅Π³ΠΎ ΠΏΡΠ°Π²ΠΈΠ»Π°. ΠΡΠΈ ΡΡΠΎΠΌ Π΄Π»Ρ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ Π΄Π΅ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΎΠ±ΡΠ΅ΠΊΡΠΎΠΌ ΡΠΎΠ²ΠΌΠ΅ΡΡΠ½ΠΎΠ³ΠΎ ΠΈΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»ΡΠ½ΠΎΠ³ΠΎ Π·Π°Π΄Π΅ΠΉΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅ΠΆΠΈΠΌΠΎΠ² ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Ρ ΡΠ°Π²Π½ΠΎΡΠ΅Π½Π½ΠΎΠΉ ΠΈΠ»ΠΈ Π½Π΅ΡΠ°Π²Π½ΠΎΡΠ΅Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΡΡ ΠΈΡ
ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π±ΡΠ»ΠΎ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½ΠΎ Π½Π΅ΡΠ΅ΡΠΊΠΎ-Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠ½ΠΎΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ ΠΎΠ±ΠΎΠ±ΡΠ΅Π½Π½ΠΎΠ³ΠΎ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π½Π°Π΄Π΅ΠΆΠ½ΠΎΡΡΠΈ Π² Π²ΠΈΠ΄Π΅ ΡΡΠ°ΠΏΠ΅ΡΠΈΠ΅Π²ΠΈΠ΄Π½ΠΎΠ³ΠΎ ΡΠΈΡΠ»Π° ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ Π΅Π³ΠΎ ΡΠ΅Π½ΡΡΠ° ΡΡΠΆΠ΅ΡΡΠΈ. ΠΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΊΠΎΠ½ΡΠΈΠ³ΡΡΠ°ΡΠΈΠΉ ΠΌΠ½ΠΎΠ³ΠΎΡΠ΅ΠΆΠΈΠΌΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΠΊΡΠ° Ρ ΠΏΠ΅ΡΠ΅ΡΡΡΠ°ΠΈΠ²Π°Π΅ΠΌΠΎΠΉ ΡΡΡΡΠΊΡΡΡΠΎΠΉ ΠΏΡΠΎΠΈΠ»Π»ΡΡΡΡΠΈΡΠΎΠ²Π°Π½Π° Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π·Π°Π΄Π°ΡΠΈ ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΊΠΎΠ½ΡΠΈΠ³ΡΡΠ°ΡΠΈΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π΄Π²ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΠΌΠ°Π»ΠΎΠ³ΠΎ ΠΊΠΎΡΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ° Β«ΠΠΈΡΡ-2ΠΒ»
Torque sensors calibration of electromechanical complexes shafts
Noncontacting torquemeters calibration is one of the acute tasks currently. Such sensors are widely used in measuring torques and torsional oscillations of elastic shafts of industrial plants and electromechanical systems. Noncontacting torquemeters must be properly calibrated before they are used to measure torque and torsional oscillations of rotating shafts. The paper describes a new approach to solving the task of calibration of noncontacting torquemeters and torsional oscillations meters of elastic shafts. The approach is based on the finite elements method as well as realized in the measuring device β torquemeter. The torquemeter allows to measure little torques and torsional oscillations of elastic shafts of electromechanical complexes
Screening of microorganisms producing biosurfactants from renewable substrates
Biosurfactants are one of the promising biotechnological products applied in agriculture. Their use, however, is currently far from economically viable, due to the expensive feedstock for the growth of microorganisms. The solution to this problem can be to reduce the cost of production by using organic waste as a nutrient substrate. In this study, oil-containing wastes were considered as substrates - waste frying sunflower oil and petroleum-contaminated soil. At the first stage of research, we screened native waste microorganisms capable of synthesizing biosurfactants. As a result of the study, strains with the ability to form biosurfactants were isolated. Six strains (A, B, C, D, E, F) were isolated from waste frying sunflower oil, two strains (A1, B1) were isolated from petroleum-contaminated soil. The highest yield of biosurfactants is typical for strains A and A1 - 0.429 and 0.502 mg ml-1, while the best ratio of biosurfactant mass to cell biomass is typical for strains A1 and E - 0.9 and 0.6. The most effective producer of biosurfactants turned out to be strain E with an emulsifying activity of E24 equal to 80% and a surface tension of the culture liquid of 27.1 mN m-1
SARS-CoV-2 Wastewater Genomic Surveillance: Approaches, Challenges, and Opportunities
During the SARS-CoV-2 pandemic, wastewater-based genomic surveillance (WWGS)
emerged as an efficient viral surveillance tool that takes into account
asymptomatic cases and can identify known and novel mutations and offers the
opportunity to assign known virus lineages based on the detected mutations
profiles. WWGS can also hint towards novel or cryptic lineages, but it is
difficult to clearly identify and define novel lineages from wastewater (WW)
alone. While WWGS has significant advantages in monitoring SARS-CoV-2 viral
spread, technical challenges remain, including poor sequencing coverage and
quality due to viral RNA degradation. As a result, the viral RNAs in wastewater
have low concentrations and are often fragmented, making sequencing difficult.
WWGS analysis requires advanced computational tools that are yet to be
developed and benchmarked. The existing bioinformatics tools used to analyze
wastewater sequencing data are often based on previously developed methods for
quantifying the expression of transcripts or viral diversity. Those methods
were not developed for wastewater sequencing data specifically, and are not
optimized to address unique challenges associated with wastewater. While
specialized tools for analysis of wastewater sequencing data have also been
developed recently, it remains to be seen how they will perform given the
ongoing evolution of SARS-CoV-2 and the decline in testing and patient-based
genomic surveillance. Here, we discuss opportunities and challenges associated
with WWGS, including sample preparation, sequencing technology, and
bioinformatics methods.Comment: V Munteanu and M Saldana contributed equally to this work A Smith and
S Mangul jointly supervised this work For correspondence:
[email protected]
A nearly complete database on the records and ecology of the rarest boreal tiger moth from 1840s to 2020
Global environmental changes may cause dramatic insect declines but over century-long time series of certain speciesβ records are rarely available for scientific research. The Menetriesβ Tiger Moth (Arctia menetriesii) appears to be the most enigmatic example among boreal insects. Although it occurs throughout the entire Eurasian taiga biome, it is so rare that less than 100 specimens were recorded since its original description in 1846. Here, we present the database, which contains nearly all available information on the speciesβ records collected from 1840s to 2020. The data on A. menetriesii records (N = 78) through geographic regions, environments, and different timeframes are compiled and unified. The database may serve as the basis for a wide array of future research such as the distribution modeling and predictions of range shifts under climate changes. It represents a unique example of a more than century-long dataset of distributional, ecological, and phenological data designed for an exceptionally rare but widespread boreal insect, which primarily occurs in hard-to-reach, uninhabited areas of Eurasia.Peer reviewe
Seasonal and annual fluxes of nutrients and organic matter from large rivers to the Arctic Ocean and surrounding seas
Author Posting. Β© The Author(s), 2011. This is the author's version of the work. It is posted here by permission of Springer for personal use, not for redistribution. The definitive version was published in Estuaries and Coasts 35 (2012): 369-382, doi:10.1007/s12237-011-9386-6.River inputs of nutrients and organic matter impact the biogeochemistry of arctic
estuaries and the Arctic Ocean as a whole, yet there is considerable uncertainty about the
magnitude of fluvial fluxes at the pan-arctic scale. Samples from the six largest arctic
rivers, with a combined watershed area of 11.3 x 106 km2, have revealed strong seasonal
variations in constituent concentrations and fluxes within rivers as well as large
differences among the rivers. Specifically, we investigate fluxes of dissolved organic
carbon, dissolved organic nitrogen, total dissolved phosphorus, dissolved inorganic
nitrogen, nitrate, and silica. This is the first time that seasonal and annual constituent
fluxes have been determined using consistent sampling and analytical methods at the pan
arctic scale, and consequently provide the best available estimates for constituent flux
from land to the Arctic Ocean and surrounding seas. Given the large inputs of river water
to the relatively small Arctic Ocean, and the dramatic impacts that climate change is
having in the Arctic, it is particularly urgent that we establish the contemporary river
fluxes so that we will be able to detect future changes and evaluate the impact of the
changes on the biogeochemistry of the receiving coastal and ocean systems.This work was supported by the National Science Foundation through grants
OPP-0229302, OPP-0519840, OPP-0732522, and OPP-0732944. Additional support was
provided by the U. S. Geological Survey (Yukon River) and the Department of Indian
and Northern Affairs (Mackenzie River)
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial
Aims The objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity in post-discharge outcomes with aliskiren in patients with and without baseline diabetes mellitus (DM). Methods and results ASTRONAUT included 953 patients without DM (aliskiren 489; placebo 464) and 662 patients with DM (aliskiren 319; placebo 343) (as reported by study investigators). Study endpoints included the first occurrence of cardiovascular death or HHF within 6 and 12 months, all-cause death within 6 and 12 months, and change from baseline in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at 1, 6, and 12 months. Data regarding risk of hyperkalaemia, renal impairment, and hypotension, and changes in additional serum biomarkers were collected. The effect of aliskiren on cardiovascular death or HHF within 6 months (primary endpoint) did not significantly differ by baseline DM status (P = 0.08 for interaction), but reached statistical significance at 12 months (non-DM: HR: 0.80, 95% CI: 0.64-0.99; DM: HR: 1.16, 95% CI: 0.91-1.47; P = 0.03 for interaction). Risk of 12-month all-cause death with aliskiren significantly differed by the presence of baseline DM (non-DM: HR: 0.69, 95% CI: 0.50-0.94; DM: HR: 1.64, 95% CI: 1.15-2.33; P < 0.01 for interaction). Among non-diabetics, aliskiren significantly reduced NT-proBNP through 6 months and plasma troponin I and aldosterone through 12 months, as compared to placebo. Among diabetic patients, aliskiren reduced plasma troponin I and aldosterone relative to placebo through 1 month only. There was a trend towards differing risk of post-baseline potassium β₯6 mmol/L with aliskiren by underlying DM status (non-DM: HR: 1.17, 95% CI: 0.71-1.93; DM: HR: 2.39, 95% CI: 1.30-4.42; P = 0.07 for interaction). Conclusion This pre-specified subgroup analysis from the ASTRONAUT trial generates the hypothesis that the addition of aliskiren to standard HHF therapy in non-diabetic patients is generally well-tolerated and improves post-discharge outcomes and biomarker profiles. In contrast, diabetic patients receiving aliskiren appear to have worse post-discharge outcomes. Future prospective investigations are needed to confirm potential benefits of renin inhibition in a large cohort of HHF patients without D
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials.
Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure.
Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen.
Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049
- β¦